Development of Fluorinated Colloidal Gold Nanoparticles as Theranostic Drug Delivery Systems

Claudia Pigliacelli 1,2 Ilaria Tirotta 1,2 Giuseppe Resnati 1,2 Pierangelo Metrangolo 1,2,3 Francesca Baldelli Bombelli 1,2,4
1Department of Chemistry, Materials, and Chemical Engineering, Politecnico di Milano, Milano, Italy
2CEN, Fondazione Centro Europeo di Nanomedicina, Milano, Italy
3VTT, Technical Research Centre of Finland, Espoo, Finland
4School of Pharmacy, University of East Anglia, Norwich, UK

In the last decades the use of nanoparticles (NPs) for biomedical applications has attracted a growing research interest, promoting NPs use in imaging, therapy, and drug delivery. [1] The possibility of combining diagnostic and therapeutic properties in unique nano-objects has led to the development of new theranostic systems, [2] which might improve the prognosis of many diseases. At the same time, fluorinated tracers represent a powerful diagnostic tool for in vivo imaging through 19F MRI detection. [3] Thus, the use of fluorinated ligands for NPs surface functionalization can bring to the development of innovative theranostic agents to be employed in nanomedicine.

In this contribution we report on a novel multifunctional nanomaterial based on gold NPs stabilized with highly fluorinated chains or with a mixture of hydrogenated and highly fluorinated ligands. These NPs were successfully transferred into an aqueous environment using two different coating amphiphilic polymers. The obtained nanodispersions were characterized by DLS, zeta-potential, 19F-NMR, FTIR, TEM and UV-VIS measurements. As shown in Figure 1, the two coating strategies produced different hybrid nanostructures. Indeed, in one case we obtained NPs formed by a single Au core coated with a layer of polymer, while in the other the NPs were composed of several Au clusters covered by a coating film. Stability studies in biological fluids such as serum and human plasma were also performed. Overall, these systems can function simultaneously as 19F-MRI contrast agents and as drug delivery systems, resulting in promising theranostic agents for biomedical applications.

  

 
1.               Doane, T.L. and C. Burda, Chemical Society Reviews, 2012. 41(7): p. 2885-2911.

2.               Motamedi, S., et al., Biomedical optics express, 2011. 2(5): p. 1194.

3.               Tirotta, I., et al., Journal of American Chemical Society, 2014, submitted.
 
 

claudia.pigliacelli@polimi.it








 




Powered by Eventact EMS